Charlottesville, VANCT07573228Now EnrollingIRB Ready

Type 1 Diabetes Clinical Trial in Charlottesville, VA

Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Charlottesville. Study-provided care at no cost to qualified participants.

Sponsored by University of Virginia

Quick Self-Assessment

See if you qualify for this Charlottesville location

Preparing your pre-screening questions…

Expert Care in Charlottesville

Access type 1 diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 1 diabetes treatment provided free

Apply for This Charlottesville Location

Check if you qualify for this type 1 diabetes clinical trial in Charlottesville, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Charlottesville

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Charlottesville site if eligible
  4. 4Begin participation

About This Type 1 Diabetes Study in Charlottesville

The purpose of this study is: * To see if insulin resistance (how sensitive your muscle tissue is to insulin) is associated with lower cardio fitness in people with Type 1 diabetes compared to healthy controls, before and after a High Intensity Interval Training (HIIT) exercise program. * To see if being overweight and having Type 1 diabetes is associated with lower cardio fitness compared to overweight healthy controls, before and after a HIIT exercise program.

Sponsor: University of Virginia

Who Can Participate

Inclusion Criteria

• Male or female ≥21 and ≤50 years old
For persons with T1D: Disease duration ≥ 5 years and HbA1c ≤ 8.5% on multiple daily insulin injection or insulin pump
Body mass index: ≥19 and ≤27 kg/m2 for control and T1D, ≥30 and ≤40 kg/m2 (27.5 to 37.5 for Asian Americans) for obesity and T1D + obesity. BMI is limited to ≤40 kg/m2 (37.5 for Asian Americans) for easier vascular access and cardiac imaging.
Stable use of non-insulin medications for over 6 months other than estrogen/progesterone containing medications which must be discontinued at least 3 months prior to the study (intrauterine devices may be continued due to limited systemic absorption)

Exclusion Criteria

• Acute or chronic disease other than T1D or obesity
History of microvascular or macrovascular diabetes complications
History of diabetic ketoacidosis in the past 24 months
History of hypoglycemia unawareness
Recently active (\>20 min of moderate/high intensity exercise, 2 times/week)
Subjects who are smokers or who have quit smoking \<5 years
Subjects with hypertriglyceridemia (\>400 mg/dl)
Current use of vasoactive medications (i.e. calcium channel blockers, angiotensin-converting enzyme or renin inhibitors, angiotensin-receptor blockers, nitrates, alpha- or beta-blockers, or diuretics).
Females taking oral contraceptives in the past 3 months
Subjects with a history of significant metabolic, cardiac, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or malignancy
Pregnant (as evidenced by positive pregnancy test) or nursing women
Musculoskeletal condition preventing participation in exercise testing or exercise training
History of gastroparesis
Pulse oximetry \<90%

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Charlottesville?

Yes, this clinical trial (NCT07573228) has an active research site in Charlottesville, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 1 Diabetes Treatment Options in Charlottesville, VA

If you're searching for type 1 diabetes treatment options in Charlottesville, VA, this clinical trial (NCT07573228) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Charlottesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 1 diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Charlottesville, VA

See all pulmonary embolism clinical trials recruiting in Charlottesville — not just this study.

Browse Pulmonary Embolism Trials in Charlottesville →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 1 Diabetes TrialsJuvenile Diabetes TrialsAll Conditions →

Ready to Join in Charlottesville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Charlottesville, VA